Sortina Pharma
PrivateLast Round
Seed
Jan 14, 2021
Company Overview
Sortina Pharma is a biotechnology company that develops small molecule therapeutics targeting sortilin for the treatment of cancer and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sortina Pharma Comparables
Compare Sortina Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesper Bio ApS | 85% | |
| Draupnir Bio | 77% | |
| Teitur Trophics | 73% | |
Sortina Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2021 |
Sortina Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Seed |
| Eir Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2021
Led by Eir Ventures with participation from Vasa Angels I.
Sortina Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sortina Pharma's valuation, stock price, and market status.